May 5, 2026
Dark blue page with title 'Economic Goodwill' and green subtitle; below is a two-by-two color block diagram: top-left 'Trader' (gray), top-right 'COMPOUNDER' (green), bottom-left 'Drift' (light gray), bottom-right 'Speculator' (orange).

Economic Goodwill: Warren Buffett’s 1983 Berkshire Letter Appendix on the Real Source of Compounding

Buffett's 1983 appendix split goodwill into two: the accountant's residual on the balance sheet, and the inflation-resistant economic goodwill that compounds wealth. Titan Biotech FY25's high returns on a modest tangible base read like the second.
May 4, 2026
Hero header announcing Walter Schloss’s 16 Factors with a two-by-two grid of panels labeled Trader, Compounder, Drift, and Speculator.

Walter Schloss’s 16 Factors: How Graham’s Quietest Disciple Beat the Market for 47 Years Without Ever Meeting Management

Walter Schloss compounded 16% for 47 years from a back office, with no MBA, no Bloomberg terminal, and no management visits. Seven of his 16 factors illustrated through Titan Biotech FY25's audited balance sheet.
May 3, 2026
Hero section with title 'The Twenty-Punch-Card Rule' and a four-color grid labeled Trader (gray), Compounder (green), Drift (light gray), Speculator (orange).

The Twenty-Punch-Card Rule: Warren Buffett’s Lifetime-Scarcity Discipline for Indian Value Investors

Buffett's twenty-slot punch card forces selectivity, patience and conviction in a single mental model. Titan Biotech's FY25 audited numbers — debt-to-equity 0.02x, ~16.9% RoCE, 103% CFO/operating profit, 55.87% promoter holding — illustrate the discipline.
May 2, 2026
Infographic showing four blocks labeled Lucky (gray), Disciplined Investor (green), Confused (light gray), Bias-Trapped (orange) under The Lollapalooza Effect.

The Lollapalooza Effect: Charlie Munger’s 1995 Harvard Doctrine on Multiplicative Forces

Charlie Munger's 1995 Harvard speech introduced the Lollapalooza Effect: when multiple forces line up in the same direction, the outcome is multiplicative, not additive. Eight audited Titan Biotech FY25 disciplines illustrate the positive mirror-image.
+91-7380122211